Skip to Content
Merck
All Photos(1)

Key Documents

Safety Information

59452

Sigma-Aldrich

(S)-2,2-Dimethyl-1,3-dioxolane-4-methanol p-toluenesulfonate

purum, ≥99.0% (sum of enantiomers, GC)

Synonym(s):

2,3-Isopropylidene-sn-glycerol 1-tosylate, L-α,β-Isopropylideneglycerol-γ-tosylate

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C13H18O5S
CAS Number:
Molecular Weight:
286.34
Beilstein:
89799
MDL number:
UNSPSC Code:
12352005
PubChem Substance ID:

grade

purum

Assay

≥99.0% (sum of enantiomers, GC)

form

solid

optical activity

[α]20/D +7.5±0.5°, c = 2% in DMF

mp

29-31 °C

storage temp.

2-8°C

SMILES string

Cc1ccc(cc1)S(=O)(=O)OC[C@@H]2COC(C)(C)O2

InChI

1S/C13H18O5S/c1-10-4-6-12(7-5-10)19(14,15)17-9-11-8-16-13(2,3)18-11/h4-7,11H,8-9H2,1-3H3/t11-/m0/s1

InChI key

SRKDUHUULIWXFT-NSHDSACASA-N

Other Notes

Chiral building block, e.g. synthesis of GABOB

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Precautionary Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

235.4 °F - closed cup

Flash Point(C)

113 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

59452-5G-F:
59452-VAR-F:
59452-BULK-F:
59452-1G-F:


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Line S Tarpgaard et al.
Oncotarget, 7(37), 59441-59457 (2016-08-11)
It is now widely accepted that therapeutic antibodies targeting epidermal growth factor receptor (EGFR) can have efficacy in KRAS wild-type advanced colorectal cancer (CRC) patients. What remains to be ascertained is whether a subgroup of KRAS-mutated CRC patients might not
M.E. Jung et al.
Journal of the American Chemical Society, 102, 6304-6304 (1980)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service